Adaptec 2011 Annual Report Download - page 29

Download and view the complete annual report

Please find page 29 of the 2011 Adaptec annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 135

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135

Table of Contents
impairment on investment securities and other included in Gain (loss) on sale of investment securities and other; $1.4 million foreign loss on foreign tax
liabilities, $0.9 million of non-cash interest expense for the accretion of the debt discount related to the senior convertible notes; $0.5 million recovery
of impairment on investment securities and other, included in Interest (expense) income, net; $18.9 million recovery of income taxes, including $10.2
million income tax recovery for adjustment relating to prior periods, $2.5 million reduction of stock option related loss carry-forwards recognized in
equity, $1.8 million recovery of arrears interest relating to unrecognized tax benefits, $1 million income tax recovery related to foreign tax credits, $0.6
million net tax recovery relating to foreign exchange translation of a foreign subsidiary, $0.4 million income tax recovery relating to intercompany
transactions, and $2.4 million deferred tax recovery related to non-deductible intangible asset amortization.
(2) Results include $0.2 million stock-based compensation expense included in Cost of revenues; $3 million stock-based compensation, $3.0 million asset
impairment, and $0.1 million acquisition-related costs included in Research and development expense; $3.7 million stock-based compensation expense,
and $0.5 million acquisition-related costs included in Selling, general and administrative; $3.2 million foreign exchange gain on foreign tax liabilities;
$0.9 million of non-cash interest expense for the accretion of the debt discount related to the senior convertible notes, and $0.4 million accretion of
liability for contingent consideration included in Interest (expense) income, net; and $5.4 million provision for income taxes, including $1.6 million
income tax provision relating to inter-company transactions, $0.9 million income tax provision relating to income from operating results; $0.8 million
net tax expense relating to foreign exchange translation of a foreign subsidiary, $1.9 million stock option related loss carry-forwards recognized in
equity, $0.4 million arrears interest relating to unrecognized tax benefits, $0.2 million income tax recovery for adjustments relating to prior periods, and
$0.1 million income tax provision related to stock-based compensation.
(3) Results include $0.3 million stock-based compensation expense included in Cost of revenues; $2.9 million stock-based compensation expense and $0.1
million acquisition-related costs included in Research and development expense; $3.9 million stock-based compensation, and $1.1 million acquisition-
related costs included in Selling and administrative expense; $0.3 million foreign exchange loss on foreign tax liabilities; $0.9 million of non-cash
interest expense for the accretion of the debt discount related to the senior convertible notes, and $0.3 million accretion of liability for contingent
consideration included in Interest (expense) income, net; and $3.7 million provision for income taxes including $1.6 million income tax provision
relating to inter-company transactions, $1.2 million net tax expense relating to foreign exchange translation of a foreign subsidiary, $1 million income
tax provision relating to income from operating results, $0.9 million reduction of stock option related loss carry-forwards recognized in equity, $0.6
million arrears interest relating to unrecognized tax benefits, $0.5 million income tax provision for adjustments relating to prior periods, and $0.3
million income tax recovery related to stock-based compensation.
(4) Results include $0.2 million stock-based compensation expense and $9.0 million acquisition-related costs included in Cost of revenues; $2.7 million
stock-based compensation expense and $0.2 million acquisition-related costs included in Research and development expense; $3.4 million stock-based
compensation expense, $1.2 million acquisition-related costs and $3.4 million lease exit costs included in Selling, general and administrative expenses;
$1 million foreign exchange loss on foreign tax liabilities; $0.9 million of non-cash interest expense for the accretion of the debt discount related to the
senior convertible notes, $0.5 million accretion of liability for contingent consideration, and $0.3 million interest related to short-term loan, included in
Interest (expense) income, net; and $5.9 million provision for income taxes including $2.2 million stock option related loss carry-forwards recognized
in equity, $3.6 million income tax provision relating to inter-company transactions, $1.9 million net tax recovery relating to foreign exchange
translation of a foreign subsidiary, $1.4 million income tax provision relating to income from operating results, and $0.6 million arrears interest relating
to unrecognized tax benefits.
(5) Results include $0.2 million stock-based compensation expense and $0.9 million acquisition related costs included in Cost of revenues; $2.3 million
stock-based compensation expense included in Research and development expense; $3.1 million stock-based compensation expense and $4.7 million
acquisition related
28